NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Guangzhou Magpie Pharmaceuticals Co., Ltd.

Guangzhou Magpie Pharmaceuticals Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://magpiepharma.com/

Last Round

Early Funding

Apr 20, 2020

Est. Valuation

$123.9M

Total Funding Raised

$28.88M

Company Overview

Guangzhou Magpie Pharmaceuticals Co., Ltd. is a biotechnology company that develops innovative small molecule drugs for the treatment of cardiovascular, cerebrovascular, neurodegenerative, and mitochondrial dysfunction diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule drugdrug discoverybiopharmaceuticalclinical-stage biotechneuroprotective agentnew chemical entitiesNCEout-licensingischemic stroke treatmentALS drugbiotech pipelinedrug developmentpreclinical researchpharma R&Ddrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Magpie Pharmaceuticals Co., Ltd. Comparables

Compare Guangzhou Magpie Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.

Guangzhou Magpie Pharmaceuticals Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prilenia Therapeutics
74%
QurAlis
74%
Simcere Pharmaceutical Group
74%

Guangzhou Magpie Pharmaceuticals Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 20, 2020
Series BFeb 12, 2019
Series A ExtensionSep 1, 2017
Series ADec 1, 2016

Guangzhou Magpie Pharmaceuticals Co., Ltd. Investors

Notable investors and investment history

Guangzhou Magpie Pharmaceuticals Co., Ltd. investors
InvestorRounds
Shenzhen Sangel Venture CapitalSeries B
Guoqian InvestmentSeries A, Series A Extension

Guangzhou Magpie Pharmaceuticals Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangzhou Magpie Pharmaceuticals Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou Magpie Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Employee Range1
Year Founded2011
Last FundingApr 20, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.